BindingDB logo
myBDB logout

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26372652 21 Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activities.EBI RWTH Aachen University
25182963 40 Synthesis of non-prenyl analogues of baccharin as selective and potent inhibitors for aldo-keto reductase 1C3.EBI Gifu Pharmaceutical University
24411201 150 Morpholylureas are a new class of potent and selective inhibitors of the type 5 17--hydroxysteroid dehydrogenase (AKR1C3).EBI University of Auckland
23845281 25 Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17-hydroxysteroid dehydrogenase inhibitor.EBI Astellas Pharma Inc.
23454516 92 Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3.EBI University of Auckland
23353746 46 2,3-diarylpropenoic acids as selective non-steroidal inhibitors of type-5 17ß-hydroxysteroid dehydrogenase (AKR1C3).EBI University of Ljubljana
23432095 160 Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17ß-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.EBI Vanderbilt University School of Medicine
22881866 57 Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library.EBI University of Ljubljana
22877157 356 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-ß-hydroxysteroid dehydrogenase AKR1C3.EBI University of Auckland
22897946 34 N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.EBI University of Ljubljana
22263837 262 Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17ß-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.EBI University of Pennsylvania
22506594 20 Selective inhibition of human type-5 17ß-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.EBI Gifu Pharmaceutical University
22507964 17 Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer.EBI Perelman School of Medicine University of Pennsylvania
21277203 24 Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17ß-hydroxysteroid dehydrogenase (AKR1C3).EBI University of Pennsylvania
20850205 27 Structure-based optimization and biological evaluation of human 20a-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors.EBI Monash University (Parkville Campus)
19397269 16 Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1).EBI Monash University (Parkville Campus)
18620380 8 Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid.BDB Monash University